Med. praxi 2013; 10(8-9): 291-293

Inflammation of the thyroid gland

MUDr.Hana Šarapatková
Interní a endokrinologická ordinace, Olomouc

Thyroid disease affects about 6–8% of the population in the Czech Republic. The proportion of women and men is 4–6 : 1. Incidence of thyroid

disease is about 15–20% of women and about 10% of men at the age over 65 years. The important part of thyroid disease is inflammation –

an inhomogeneous group of diseases of different etiopathogenesis. All have inflammatory manifestation followed by function disorder.

According to the course of the disease we can distinguish acute, subacute and chronic thyroiditis. The chronic thyroiditis is frequently

ocured in practice. Chronic lymphocytic thyroiditis (as organ specific autoimmune diseases) is often associated with other autoimmune

diseases. This common occurrence of several autoimmune diseases is often called autoimmune polyorgan syndrome (APS). In practice,

besides the overlapping chronic lymphocytic thyroiditis with diabetes mellitus type I, we meet with celiac disease, vitiligo, inflammatory

bowel disease, pernicious anemia and systemic connective tissue diseases (rheumatoid arthritis, Bechterew's disease).

Keywords: thyroiditis, acute thyroiditis, chronic thyroiditis, subacute thyroiditis

Published: September 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šarapatková H. Inflammation of the thyroid gland. Med. praxi. 2013;10(8-9):291-293.
Download citation

References

  1. Salátová M, Zamrazil V. Výskyt a charakter onemocnění štítné žlázy ve stáří. In: Stárka L. a kol.: Pokroky v endokrinologii, Maxdorf Praha: 332-345.
  2. Vlček P. Moderní endokrinologická diagnostika poruch štítné žlázy Klin. Biochem. Metab. 2010; 18(39) No 3: 132-135.
  3. Halenka M, Skodova I, Horak D, et al. Thyroid Abscess as a Complication of Fine-Needle Aspiration Biopsy. The Endocrinologist 2008; 18: 263-265. Go to original source...
  4. Espino MA, Medina PM, González MC, et al. Subacute thyroiditis associated with positive antibodies to the Epstein-Barr virus. An Med Interna 2000; 17(10): 546-548.
  5. Nyulassy Š, Hnilica P, Buc M, et al. Subacute (de Quervain's) Thyroiditis: Association with HLA-Bw35 Antigen and Abnormalities of the Complement System, Immunoglobulins and Other Serum Proteins JCEM 1977; 45: 270-274. Go to original source...
  6. Ohsako N, Tamai H, Sudo T, et al. Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing. J Clin Endocrinol Metab. 1995; 80(12): 3653-3656. Go to original source... Go to PubMed...
  7. Kramer AB, Roozendaal C, Dullaart RP. Familial occurrence of subacute thyroiditis associated with human leukocyte antigen-B35. Thyroid 2004; 14(7): 544-347. Go to original source... Go to PubMed...
  8. Fatourechi V, Aniszewski JP, Fatourechi GZ, et al. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab 2003; 88: 2100. Go to original source... Go to PubMed...
  9. Benbassat CA, Olchovsky D, Tsvetov G, Shimon I. Subacute thyroiditis: clinical characteristics and treatment outcome in fifty-six consecutive patients diagnosed between 1999 and 2005. J Endocrinol Invest 2007; 30: 631. Go to original source... Go to PubMed...
  10. Nishihara E, Ohye H, Amino N, et al. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med 2008; 47: 725. Go to original source... Go to PubMed...
  11. Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev. 2003; 24(5): 694-717. Go to original source... Go to PubMed...
  12. Ban Y, Tomer Y. Susceptibility genes in thyroid autoimmunity. Clin Dev Immunol. 2005; 12(1): 47-58. Go to original source... Go to PubMed...
  13. Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity. Thyroid. 2007; 17(10): 949-961. Go to original source... Go to PubMed...
  14. Volpé R. Thyroiditis: current views of pathogenesis.The Medical Clinics of North America 1975; 59(5): 1163-1175. Go to original source... Go to PubMed...
  15. Jiskra J. Význam autoimunity u onemocnění štítné žlázy. In: Límanová Z. (ed.): Štítná žláza, Galén Praha: 167-177.
  16. Miller BS, Paul G. Gauger PG. Thyroid Lymphoma Arising from Hashimoto's Thyroiditis. JCEM 1, 2006; 91(10): 3711-3712. Go to original source... Go to PubMed...
  17. Ruggiero FP, Frauenhoffer E, Stack Jr BC. Thyroid lymphoma: a single institution's experience. Otolaryngol Head Neck Surg 2005; 133: 888-896. Go to original source...
  18. Repplinger D, Bargren A, Zhang YW, et al. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res. 2008; 150(1): 49-52. Go to original source... Go to PubMed...
  19. Cipolla C, Sandonato L, Graceffa G, et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am. Surg. 2005; 71: 874-878. Go to original source... Go to PubMed...
  20. Ahn D, Heo SJ, Park JH, et al. Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer. Acta Oncol. 2011; 50(8): 1228-1234. Go to original source... Go to PubMed...
  21. Papi G, LiVolsi VA. Current Concepts on Riedel Thyroiditis. Am J Clin Pathol 2004; 121(Suppl. 1): S50-S63. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.